Navamedic ASA (FRA:N1A) EBIT per Share : €0.09 (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Navamedic ASA EBIT per Share?

Navamedic ASA's EBIT per Share for the six months ended in Dec. 2023 was €0.06. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.09.

During the past 12 months, the average EBIT per Share Growth Rate of Navamedic ASA was -13.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Navamedic ASA's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Navamedic ASA was 69.00% per year. The lowest was -207.90% per year. And the median was 12.60% per year.

FRA:N1A's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Distribution industry.
Industry Median: 9.4
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Navamedic ASA's EBIT for the six months ended in Dec. 2023 was €1.01 Mil.

Navamedic ASA EBIT per Share Historical Data

The historical data trend for Navamedic ASA's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navamedic ASA EBIT per Share Chart

Navamedic ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.12

-0.09

0.03

0.24

0.09

Navamedic ASA Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT per Share	Get a 7-Day Free Trial															0.02	0.08	0.17	0.03	0.06

Navamedic ASA EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Navamedic ASA's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	1.617	/	17.574
=	0.09

Navamedic ASA's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	1.012	/	17.574
=	0.06

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.09

Navamedic ASA (FRA:N1A) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Navamedic ASA EBIT per Share Related Terms

Thank you for viewing the detailed overview of Navamedic ASA's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Navamedic ASA (FRA:N1A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Navamedic ASA (FRA:N1A) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

NAVA:Norway

Address

Henrik Ibsensgate 100, Solli Plass, Lysaker, NOR, N-0255

Website

https://www.navamedic.com

Navamedic ASA is a pharmaceutical company that operates in a single segment, which is marketing, selling, and distributing pharmaceuticals and medical nutrition products to hospitals, pharmacies, and patients, bought from product suppliers and manufacturers in Europe and other places. Its product categories include Medical nutrition, Consumer health, Branded generics, and Specialty pharma.

Navamedic ASA (FRA:N1A) Headlines

No Headlines